SCHEMBL7979360

SCHEMBL7979360

CCn1c2ccccc2c2cc(NC(=O)N3CCC(COc4ccccc4)CC3)ccc21

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
REV1 Q9UBZ9 1/20 0.69
MAPT P10636 12/20 0.64
KDM4E B2RXH2 8/20 0.64
HPGD P15428 5/20 0.64
ALDH1A1 P00352 5/20 0.64
LMNA P02545 5/20 0.64
MEN1 O00255 4/20 0.64
KMT2A Q03164 4/20 0.64
SMN1; SMN2 Q16637 4/20 0.64
RAB9A P51151 4/20 0.64
NPC1 O15118 3/20 0.64
NPY5R Q15761 3/20 0.64
GAA P10253 1/20 0.56
FAAH O00519 1/20 0.55
MCHR2 Q969V1 1/20 0.55
NPSR1 Q6W5P4 1/20 0.54
TP53 P04637 2/20 0.54
RORC P51449 2/20 0.54
HCRTR1 O43613 2/20 0.52
PAX8 Q06710 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7977012 0.86 REV1 (0.68) REV1MAPTKDM4EHPGDALDH1A1
SCHEMBL7973739 0.84 REV1 (0.84) REV1MAPTKDM4EHPGDALDH1A1
SCHEMBL7977372 0.81 REV1 (0.81) REV1MAPTKDM4EHPGDALDH1A1
SCHEMBL7963464 0.79 NPY5R (1.00) REV1MAPTKDM4EHPGDALDH1A1
SCHEMBL4728756 0.78 MAPT (1.00) MAPTKDM4EHPGDALDH1A1LMNA
SCHEMBL7963513 0.77 MAPT (0.83) REV1MAPTKDM4EHPGDALDH1A1
SCHEMBL8670954 0.72 HTR1A (0.68)
SCHEMBL7722815 0.72 NPSR1 (1.00) REV1MAPTKDM4EHPGDALDH1A1
SCHEMBL5735456 0.72 REV1 (0.62) REV1MAPTKDM4EHPGDALDH1A1
SCHEMBL3592414 0.71 FAAH (1.00) MAPTKDM4EHPGDALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001007409-A1 CARBAZOLE DERIVATIVES AND THEIR USE AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS ASTRAZENECA UK LIMITED (GB) 2001-02-01 WO disclosed